A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Combination Compared to Zibotentan Monotherapy as well as Zibotentan/Dapagliflozin and Zibotentan Monotherapy Compared to Placebo in Participants with Cirrhosis

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Lewis, Paula (Project Manager)

Project: Research

Project Details

Effective start/end date2/04/241/04/26


  • Clinical Trials
  • D4326C00004